News

The EverFlex+ Self-Expanding Peripheral Stent System is the advanced version of EverFlex stent technology for the treatment of peripheral arterial disease. The new EverFlex+ system is designed to

The joint venture is expected to be renamed as Vertellus Specialty Materials (India) for the marketing and distribution of specialty chemicals globally Vertellus Specialties is the majority partner

The new system, which will help in the production of self-adhesive labels, consists of machine mounted cameras that compare every label produced to the customer’s approved artwork. The

TransPharma’s ViaDor drug delivery system incorporates a handheld electronic device, which creates microscopic passageways through the outer layer of the skin allowing for transdermal delivery of a wide

PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain. According to Archimedes Pharma, the SMC’s

The research centre was dedicated by the Chancellor of Manipal University, Ramdas Pai. Pai said the safe conduct of studies for Indian and global companies, leveraging the scientific

The data, compiled from 479 patients enrolled in a randomized controlled trial being conducted to obtain US Food and Drug Administration PMA clearance for the device, showed that

The Phase III trial will enroll approximately 250 patients across Japan, Singapore, China, Korea, and Taiwan, and is scheduled to run until June 2013. In the trial, three

The study enrolls 100 patients at seven investigative sites throughout the US and the initial data were compiled at nine months post-procedure and benchmarked against well-established performance data.